They found several markers to be elevated in those with IBD, with myeloperoxidase (MPO; AUC 0.85) and FC (AUC 0.85) demonstrating the best overall accuracy in distinguishing IBD from SCs. This evidence concerns the gene MPO and irritable bowel syndrome.